Clinical Phase 2 Multicenter Trial Of PF-00299804 In Patients With Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck.
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2012
At a glance
- Drugs Dacomitinib (Primary)
- Indications Head and neck cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 06 Jun 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 06 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.